Back to results
US 5,952,389 AGranted
Methods of treating tardive dyskinesia and other movement disorders
AssigneeSynchroneuron, LLC
InventorBarry S. Fogel
Life of this patent
Estimating the term…
Abstract
Disclosed is a method for treating a hyperkinetic movement disorder comprising the steps of selecting a first at least one pharmacologically active agent that acts as a GABA-receptor agonist and a second at least one pharmacologically active agent that acts as a NMDA-type glutamate receptor antagonist, and administering the first and second agents at effective and non-toxic dosages.
Claims16
A method of treating hyperkinesia comprising:
- administering an effective and non-toxic dose of an agent which is a GABA-receptor agonist and which decreases the response of NMDA-type glutamate receptors.
A method of treating a hyperkinetic movement disorder comprising the steps of:
- selecting a first at least one pharmacologically active agent that acts as a GABA-receptor agonist and a second at least one pharmacologically active agent that acts as a NMDA-type glutamate receptor antagonist;
- and
- administering said first and said second agents at effective and non-toxic dosages.
Dependencies are inferred from the claim text.